FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200119945> ?p ?o ?g. }

• W4200119945 endingPage "46" @default.
• W4200119945 startingPage "46" @default.
• W4200119945 abstract "Cisplatin (CDDP), one of the most eminent cancer chemotherapeutic agents, has been successfully used to treat more than half of all known cancers worldwide. Despite its effectiveness, CDDP might cause severe toxic adverse effects on multiple body organs during cancer chemotherapy, including the kidneys, heart, liver, gastrointestinal tract, and auditory system, as well as peripheral nerves causing severely painful neuropathy. The latter, among other pains patients feel during chemotherapy, is an indication for the use of analgesics during treatment with CDDP. Different types of analgesics, such as acetaminophen, non-steroidal anti-inflammatory drugs (NSAIDS), and narcotic analgesics, could be used according to the severity of pain. Administered analgesics might modulate CDDP's efficacy as an anticancer drug. NSAIDS, on one hand, might have cytotoxic effects on their own and few of them can potentiate CDDP's anticancer effects via inhibiting the CDDP-induced cyclooxygenase (COX) enzyme, or through COX-independent mechanisms. On the other hand, some narcotic analgesics might ameliorate CDDP's anti-neoplastic effects, causing chemotherapy to fail. Concerning safety, some analgesics share the same adverse effects on normal tissues as CDDP, augmenting its potentially hazardous effects on organ impairment. This article offers an overview of the reported literature on the interactions between analgesics and CDDP, paying special attention to possible mechanisms that modulate CDDP's cytotoxic efficacy and potential adverse reactions." @default.
• W4200119945 created "2021-12-31" @default.
• W4200119945 creator A5061137778 @default.
• W4200119945 creator A5062599655 @default.
• W4200119945 date "2021-12-28" @default.
• W4200119945 modified "2023-09-25" @default.
• W4200119945 title "Interactions of Analgesics with Cisplatin: Modulation of Anticancer Efficacy and Potential Organ Toxicity" @default.
• W4200119945 cites W1240888426 @default.
• W4200119945 cites W1269276177 @default.
• W4200119945 cites W1601876536 @default.
• W4200119945 cites W1749408641 @default.
• W4200119945 cites W1964010096 @default.
• W4200119945 cites W1980411311 @default.
• W4200119945 cites W1987604182 @default.
• W4200119945 cites W1988290501 @default.
• W4200119945 cites W1988371782 @default.
• W4200119945 cites W2008877866 @default.
• W4200119945 cites W2012754864 @default.
• W4200119945 cites W2018099503 @default.
• W4200119945 cites W2020625858 @default.
• W4200119945 cites W2044322294 @default.
• W4200119945 cites W2045973915 @default.
• W4200119945 cites W2046931181 @default.
• W4200119945 cites W2050697058 @default.
• W4200119945 cites W2054690866 @default.
• W4200119945 cites W2074544041 @default.
• W4200119945 cites W2082399279 @default.
• W4200119945 cites W2089015546 @default.
• W4200119945 cites W2106548400 @default.
• W4200119945 cites W2113577242 @default.
• W4200119945 cites W2114410648 @default.
• W4200119945 cites W2120950553 @default.
• W4200119945 cites W2131770286 @default.
• W4200119945 cites W2143967366 @default.
• W4200119945 cites W2150922140 @default.
• W4200119945 cites W2151093913 @default.
• W4200119945 cites W2157720612 @default.
• W4200119945 cites W2412658566 @default.
• W4200119945 cites W2491532174 @default.
• W4200119945 cites W2529359491 @default.
• W4200119945 cites W2529720716 @default.
• W4200119945 cites W2535384829 @default.
• W4200119945 cites W2551975978 @default.
• W4200119945 cites W2591750377 @default.
• W4200119945 cites W2592611033 @default.
• W4200119945 cites W2622070133 @default.
• W4200119945 cites W2791131687 @default.
• W4200119945 cites W2791189751 @default.
• W4200119945 cites W2795139701 @default.
• W4200119945 cites W2799908342 @default.
• W4200119945 cites W2802340168 @default.
• W4200119945 cites W2903949914 @default.
• W4200119945 cites W2908334956 @default.
• W4200119945 cites W2910919214 @default.
• W4200119945 cites W2919799243 @default.
• W4200119945 cites W2937766145 @default.
• W4200119945 cites W2938216505 @default.
• W4200119945 cites W2952260938 @default.
• W4200119945 cites W2953718521 @default.
• W4200119945 cites W2955097672 @default.
• W4200119945 cites W2965008467 @default.
• W4200119945 cites W2965091131 @default.
• W4200119945 cites W2966088674 @default.
• W4200119945 cites W2971172765 @default.
• W4200119945 cites W2973965923 @default.
• W4200119945 cites W2979014823 @default.
• W4200119945 cites W2987357793 @default.
• W4200119945 cites W2997217740 @default.
• W4200119945 cites W2999346926 @default.
• W4200119945 cites W3001385677 @default.
• W4200119945 cites W3007949955 @default.
• W4200119945 cites W3010466235 @default.
• W4200119945 cites W3011107806 @default.
• W4200119945 cites W3011267194 @default.
• W4200119945 cites W3011915645 @default.
• W4200119945 cites W3014094733 @default.
• W4200119945 cites W3025983818 @default.
• W4200119945 cites W3041729570 @default.
• W4200119945 cites W3044569728 @default.
• W4200119945 cites W3048660918 @default.
• W4200119945 cites W3083855666 @default.
• W4200119945 cites W3084116339 @default.
• W4200119945 cites W3086910589 @default.
• W4200119945 cites W3091738296 @default.
• W4200119945 cites W3092564365 @default.
• W4200119945 cites W3093194818 @default.
• W4200119945 cites W3094384494 @default.
• W4200119945 cites W3096210734 @default.
• W4200119945 cites W3104448717 @default.
• W4200119945 cites W3109864710 @default.
• W4200119945 cites W3123265388 @default.
• W4200119945 cites W3129192320 @default.
• W4200119945 cites W3130638940 @default.
• W4200119945 cites W3131601123 @default.
• W4200119945 cites W3137126526 @default.
• W4200119945 cites W3138395426 @default.
• W4200119945 cites W3141677542 @default.
• W4200119945 cites W3150252631 @default.

• next